<VariationArchive VariationID="1395238" VariationName="NM_005629.4(SLC6A8):c.1496-1_1510del" VariationType="Deletion" Accession="VCV001395238" Version="4" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-03-05" DateCreated="2022-03-28" MostRecentSubmission="2024-02-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1412252" VariationID="1395238">
      <GeneList>
        <Gene Symbol="SLC6A8" FullName="solute carrier family 6 member 8" GeneID="6535" HGNC_ID="HGNC:11055" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="153687926" stop="153696593" display_start="153687926" display_stop="153696593" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="152953751" stop="152962047" display_start="152953751" display_stop="152962047" Strand="+" />
          </Location>
          <OMIM>300036</OMIM>
          <Haploinsufficiency last_evaluated="2020-11-10" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SLC6A8">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-11-10" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SLC6A8">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_005629.4(SLC6A8):c.1496-1_1510del</Name>
      <CanonicalSPDI>NC_000023.11:153694529:CAGGAGCTGACCGCTTCA:CA</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>Xq28</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="153694530" stop="153694545" display_start="153694530" display_stop="153694545" variantLength="16" positionVCF="153694529" referenceAlleleVCF="GCAGGAGCTGACCGCTT" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="152959985" stop="152960000" display_start="152959985" display_stop="152960000" variantLength="16" positionVCF="152959984" referenceAlleleVCF="GCAGGAGCTGACCGCTT" alternateAlleleVCF="G" />
      </Location>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_012016.2" sequenceAccession="NG_012016" sequenceVersion="2" change="g.11236_11251del">
            <Expression>NG_012016.2:g.11236_11251del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.152959987_152960002del" Assembly="GRCh37">
            <Expression>NC_000023.10:g.152959987_152960002del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.153694532_153694547del" Assembly="GRCh38">
            <Expression>NC_000023.11:g.153694532_153694547del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_005629.4" sequenceAccession="NM_005629" sequenceVersion="4" change="c.1496-1_1510del" MANESelect="true">
            <Expression>NM_005629.4:c.1496-1_1510del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001574" Type="splice acceptor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001142805.2" sequenceAccession="NM_001142805" sequenceVersion="2" change="c.1466-1_1480del">
            <Expression>NM_001142805.2:c.1466-1_1480del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001574" Type="splice acceptor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001142806.1" sequenceAccession="NM_001142806" sequenceVersion="1" change="c.1151-1_1165del">
            <Expression>NM_001142806.1:c.1151-1_1165del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001574" Type="splice acceptor variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="2148364395" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_005629.4(SLC6A8):c.1496-1_1510del AND Creatine transporter deficiency" Accession="RCV001891335" Version="4">
        <ClassifiedConditionList TraitSetID="3187">
          <ClassifiedCondition DB="MedGen" ID="C1845862">Creatine transporter deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-02-17" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2021-02-17" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2022-03-28" MostRecentSubmission="2024-02-28">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">16199547</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22281021</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22644605</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="3187" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1686" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Creatine deficiency, X-linked</ElementValue>
                <XRef ID="Creatine+Deficiency%2C+X-Linked/2001" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Mental retardation , X-linked with seizures, short stature and midface hypoplasia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Mental retardation , X-linked, with creatine transport deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">X-linked creatine transporter deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">X-linked creatine deficiency syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">SLC6A8-Related Creatine Transporter Deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">CEREBRAL CREATINE DEFICIENCY SYNDROME 1</ElementValue>
                <XRef Type="MIM" ID="300352" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300036.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300036.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300036.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300036.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300036.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300036.0007" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300036.0009" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300036.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300036.0008" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300036.0010" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Creatine transporter deficiency</ElementValue>
                <XRef ID="MONDO:0010305" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">CREATINE TRANSPORTER DEFECT</ElementValue>
                <XRef Type="MIM" ID="300352" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">CCDS1</ElementValue>
                <XRef Type="MIM" ID="300352" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">The creatine deficiency disorders (CDDs), inborn errors of creatine metabolism and transport, comprise three disorders: the creatine biosynthesis disorders guanidinoacetate methyltransferase (GAMT) deficiency and L-arginine:glycine amidinotransferase (AGAT) deficiency; and creatine transporter (CRTR) deficiency. Developmental delay and cognitive dysfunction or intellectual disability and speech-language disorder are common to all three CDDs. Onset of clinical manifestations of GAMT deficiency (reported in ~130 individuals) is between ages three months and two years; in addition to developmental delays, the majority of individuals have epilepsy and develop a behavior disorder (e.g., hyperactivity, autism, or self-injurious behavior), and about 30% have movement disorder. AGAT deficiency has been reported in 16 individuals; none have had epilepsy or movement disorders. Clinical findings of CRTR deficiency in affected males (reported in ~130 individuals) in addition to developmental delays include epilepsy (variable seizure types and may be intractable) and behavior disorders (e.g., attention deficit and/or hyperactivity, autistic features, impulsivity, social anxiety), hypotonia, and (less commonly) a movement disorder. Poor weight gain with constipation and prolonged QTc on EKG have been reported. While mild-to-moderate intellectual disability is commonly observed up to age four years, the majority of adult males with CRTR deficiency have been reported to have severe intellectual disability. Females heterozygous for CRTR deficiency are typically either asymptomatic or have mild intellectual disability, although a more severe phenotype resembling the male phenotype has been reported.</Attribute>
                <XRef ID="NBK3794" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="1608" />
                <XRef ID="1608" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301745</ID>
                <ID Source="BookShelf">NBK3794</ID>
              </Citation>
              <XRef ID="52503" DB="Orphanet" />
              <XRef ID="C1845862" DB="MedGen" />
              <XRef ID="MONDO:0010305" DB="MONDO" />
              <XRef Type="MIM" ID="300352" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="4175784" SubmissionDate="2024-02-07" DateLastUpdated="2024-02-28" DateCreated="2022-03-28">
        <ClinVarSubmissionID localKey="13139845|MedGen:C1845862" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002162610" DateUpdated="2024-02-28" DateCreated="2022-03-28" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-02-17">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">22644605</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16199547</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22281021</ID>
          </Citation>
          <Comment>This variant has not been reported in the literature in individuals with SLC6A8-related conditions. For these reasons, this variant has been classified as Pathogenic. This variant disrupts the p.Gly499 amino acid residue in SLC6A8. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 22644605). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site, but this prediction has not been confirmed by published transcriptional studies. This variant is not present in population databases (ExAC no frequency). This variant results in the deletion of part of exon 11 (c.1496-1_1510del) of the SLC6A8 gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in SLC6A8 are known to be pathogenic (PMID: 22281021).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC6A8" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000023.10:g.152959985_152960000del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1845862" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11173117</SubmissionName>
          <SubmissionName>SUB14200269</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="4175784" TraitType="Disease" MappingType="XRef" MappingValue="C1845862" MappingRef="MedGen">
        <MedGen CUI="C1845862" Name="Creatine transporter deficiency" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

